DST Foundation

Emissions of remedies

Full list of emissions of pharmaceuticals and curative plants: Actovegin, Allergy treatment, Arbidol, Deltaran, Dilacor, Esentiale, Fosamax, Liver treatment, Noni, Prednisolone, Preductal, Samprost, Soursop, Ursosan, Weight loss complex.


DST Foundation - is a non-profit, charitable organization that is implementing innovative projects to promote scientific developments to the global market.

Our major projects are the newest medical technologies at the stage of research. Each of the products is a breakthrough in areas of preliminary medical treatment, treatment or diagnostics of various illnesses.

DST Foundation was created on the basis of “BioMseT” company that since 2003 has been promoting the research conducted by Russian scientists to global market. The Foundation, as a charitable, non-profit organization emerged, when the scale and significance of the projects grew beyond the framework of a single commercial organization. There was a need to involve experts from different fields of sciences and investors for the development of such big projects. It became obvious that information about the new developments and the opportunities that they open must be available to broad public.

The Foundation's portfolio includes such projects as “Artificial blood substitute based on perfluoro compounds”, “Nano-dialysis – biological fluids separation”, “DST therapy – prevention and treatment of oncological diseases”.

In the course of work and project development, practical application of the new physical phenomenon was discovered. Based on this discovery, the scientists developed a system and designed technology for reception and transmission of the properties (emission) of organic and inorganic substances and biological objects. This was the beginning of the emission project.

The significance of the discovery of the physical phenomenon consists in the following: it creates an entirely different approach to medical diagnostics and treatment in general. The newly created system and new technology dramatically changes the modern concept of information transfer within the system of modern communications.

DST Foundation objective is facilitation of practical integration of the abovementioned developments into the global market.

Tasks of the DST Foundation:

• Distribution of information concerning medical and technological innovations

• Practical involvement of scientists and doctors in the projects

• Fundraising to make the necessary research possible.

You can find information related to each of the projects on the DST Foundation website at www.dst-fund.com | www.dst-fund.ru. If you want to get more information or ask a question, please contact us by phone or e-mail.

E-mail: info@dst-fund.com 

  • Emission

    The essence of the “Emission” project is the possibility to transmit emission (properties) of organic and inorganic substances and biological objects remotely via communication lines using Internet addressing system.

  • Artificial Blood Substitute

    Authors of the invention: Ph.D. Biology, Candidate of Chemical Sciences, Kuznetsova Irina and Ph.D. Medicine Evgeny Maevsky. AT300 was developed on the basis of the Russian Scientific-Research Institute of Hematology and Transfusion Medicine, St. Petersburg.

  • Cancer treatment

    Dissymetric therapy (anisotropizing) tinctorial therapy (DST) – is an innovative method of oncological diseases treatment. It is based on the theory of Professor Kutushov about the causes of cancer and it's development.